• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠后遗症对健康状况和日常生活活动的影响:PRIME 后新冠研究。

Impact of post-COVID-19 condition on health status and activities of daily living: the PRIME post-COVID study.

机构信息

Department of Research and Education, Ciro, Horn, The Netherlands

Department of Respiratory Medicine, School of Nutrition and Translational Research in Metabolism (NUTRIM), Faculty of Health, Medicine, and Life Sciences, Maastricht University Medical Centre+, Maastricht, The Netherlands.

出版信息

Thorax. 2024 Apr 15;79(5):457-464. doi: 10.1136/thorax-2023-220504.

DOI:10.1136/thorax-2023-220504
PMID:38499346
Abstract

OBJECTIVE

To assess health and activities of daily living (ADL) in SARS-CoV-2-positive adults with and without post-COVID-19 condition (PCC) and compare this with negative tested individuals. Furthermore, different PCC case definitions were compared with SARS-CoV-2-negative individuals.

METHODS

All adults tested PCR positive for SARS-CoV-2 at the Public Health Service South Limburg (Netherlands) between June 2020 and November 2021 (n=41 780) and matched PCR negative individuals (2:1, on age, sex, year-quarter test, municipality; n=19 875) were invited by email. Health (five-level EuroQol five-dimension (EQ5D) index and EuroQol visual analogue scale (EQVAS)) and ADL impairment were assessed. PCC classification was done using the WHO case definition and five other common definitions.

RESULTS

In total, 8409 individuals (6381 SARS-CoV-2 positive; 53±15 years; 57% female; 9 (7-11) months since test) were included. 39.4% of positives had PCC by the WHO case definition (EQVAS: 71±20; EQ5D index: 0.800±0.191; ADL impairment: 30 (10-70)%) and perceived worse health and more ADL impairment than negatives, that is, difference of -8.50 points (95% CI -9.71 to -7.29; p<0.001) for EQVAS, which decreased by 1.49 points (95% CI 0.86 to 2.12; p<0.001) in individuals with PCC for each comorbidity present, and differences of -0.065 points (95% CI -0.074 to -0.056; p<0.001) for EQ5D index, and +16.72% (95% CI 15.01 to 18.43; p<0.001) for ADL impairment. Health and ADL impairment were similar in negatives and positives without PCC. Replacing the WHO case definition with other PCC definitions yielded comparable results.

CONCLUSIONS

Individuals with PCC have substantially worse health and more ADL impairment than negative controls, irrespective of the case definition. Authorities should inform the public about the associated burden of PCC and enable adequate support.

摘要

目的

评估 SARS-CoV-2 阳性成年人中伴有和不伴有新冠后疾病(PCC)的健康状况和日常生活活动能力(ADL),并将其与新冠检测阴性个体进行比较。此外,还比较了不同的 PCC 病例定义与 SARS-CoV-2 阴性个体的比较。

方法

所有在 2020 年 6 月至 2021 年 11 月期间在南林堡公共卫生服务(荷兰)PCR 检测 SARS-CoV-2 阳性的成年人(n=41780)和年龄、性别、季度检测、市匹配的 2:1PCR 阴性个体(n=19875)均收到电子邮件邀请。评估健康状况(五个级别的欧洲五维健康量表(EQ5D)指数和 EQ 视觉模拟量表(EQVAS))和 ADL 损伤情况。使用世界卫生组织病例定义和其他五个常见定义对 PCC 进行分类。

结果

共有 8409 人(6381 例 SARS-CoV-2 阳性;53±15 岁;57%为女性;检测后 9(7-11)个月)入组。根据世界卫生组织病例定义,39.4%的阳性患者患有 PCC(EQVAS:71±20;EQ5D 指数:0.800±0.191;ADL 损伤:30(10-70)%),且自我报告的健康状况和 ADL 损伤程度比阴性患者更差,即 EQVAS 差 8.50 分(95%CI-9.71 至-7.29;p<0.001),且每存在一种合并症,EQVAS 降低 1.49 分(95%CI 0.86 至 2.12;p<0.001),EQ5D 指数差 0.065 分(95%CI-0.074 至-0.056;p<0.001),ADL 损伤增加 16.72%(95%CI 15.01 至 18.43;p<0.001)。阴性患者和无 PCC 的阳性患者的健康状况和 ADL 损伤相似。用其他 PCC 定义替代世界卫生组织病例定义,结果相似。

结论

无论采用哪种病例定义,患有 PCC 的患者的健康状况和 ADL 损伤程度均明显差于阴性对照者。有关部门应告知公众 PCC 的相关负担,并提供适当的支持。

相似文献

1
Impact of post-COVID-19 condition on health status and activities of daily living: the PRIME post-COVID study.新冠后遗症对健康状况和日常生活活动的影响:PRIME 后新冠研究。
Thorax. 2024 Apr 15;79(5):457-464. doi: 10.1136/thorax-2023-220504.
2
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
3
The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.样本采集部位和采集程序对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染鉴定的影响。
Cochrane Database Syst Rev. 2024 Dec 16;12(12):CD014780. doi: 10.1002/14651858.CD014780.
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
5
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
6
Laboratory-based molecular test alternatives to RT-PCR for the diagnosis of SARS-CoV-2 infection.基于实验室的分子检测替代 RT-PCR 用于 SARS-CoV-2 感染的诊断。
Cochrane Database Syst Rev. 2024 Oct 14;10(10):CD015618. doi: 10.1002/14651858.CD015618.
7
Thoracic imaging tests for the diagnosis of COVID-19.用于 COVID-19 诊断的胸部影像学检查。
Cochrane Database Syst Rev. 2022 May 16;5(5):CD013639. doi: 10.1002/14651858.CD013639.pub5.
8
Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.奈玛特韦片/利托那韦片组合包装用于 COVID-19 的预防和治疗。
Cochrane Database Syst Rev. 2022 Sep 20;9(9):CD015395. doi: 10.1002/14651858.CD015395.pub2.
9
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.用于治疗 COVID-19 的 SARS-CoV-2 中和单克隆抗体。
Cochrane Database Syst Rev. 2021 Sep 2;9(9):CD013825. doi: 10.1002/14651858.CD013825.pub2.
10
Workplace interventions to reduce the risk of SARS-CoV-2 infection outside of healthcare settings.工作场所干预措施以降低医疗机构外 SARS-CoV-2 感染的风险。
Cochrane Database Syst Rev. 2022 May 6;5(5):CD015112. doi: 10.1002/14651858.CD015112.pub2.

引用本文的文献

1
Trajectories of Health-Related Quality of Life 2 Years After Mild/Moderate Severe Acute Respiratory Syndrome Coronavirus 2 Infection in the Pre-Omicron Era.在奥密克戎时代之前,轻度/中度严重急性呼吸综合征冠状病毒2感染后2年的健康相关生活质量轨迹。
Open Forum Infect Dis. 2025 Mar 27;12(5):ofaf142. doi: 10.1093/ofid/ofaf142. eCollection 2025 May.
2
Short and long-term trajectories of the post COVID-19 condition: Results from the EuCARE POSTCOVID study.新冠后状况的短期和长期轨迹:EuCARE POSTCOVID研究结果
BMC Infect Dis. 2025 Apr 29;25(1):625. doi: 10.1186/s12879-025-10805-w.